Product Name | MF | CAS | Details |
---|
4-Chloro-2-(cyanomethyl)benzene-1-sulfonyl chloride | C8H5Cl2NO2S | 1557469-14-3 | Details |
4-(4-Ethoxyphenyl)piperidine hydrochloride | C13H20ClNO | 170856-82-3 | Details |
2-Amino-3-(1,3-oxazol-4-yl)propanoic acid hydrochloride | C6H9ClN2O3 | 2247102-32-3 | Details |
Sitagliptin | C16H15F6N5O | 486460-32-6 | Details |
2-(2-Chlorophenyl)-1-(piperazin-1-yl)ethan-1-one hydrochloride | C12H16Cl2N2O | 1210013-45-8 | Details |
JMJD5 antibody | Details |
3-(6-Fluoro-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid | C12H12FNO3 | 1155516-10-1 | Details |
ARHGAP20 Blocking Peptide | Details |
2-(Pyridin-2-yl)-2,3-dihydro-1H-isoindol-4-amine | C13H13N3 | 1017388-43-0 | Details |
Desoxygambogenin | C38H48O6 | 173614-93-2 | Details |
Cyclo(hpro-Leu) | C11H18N2O3 | 1016899-93-6 | Details |
2-Phenyl-1-(pyridin-4-yl)ethan-1-one | C13H11NO | 1017-24-9 | Details |
3-Chloro-2-nitrobenzaldehyde | C7H4ClNO3 | 22233-52-9 | Details |
8-Fluoroimidazo[1,2-a]pyridine-2-carbaldehyde | C8H5FN2O | 1020033-80-0 | Details |
γ-Polyglutamic acid sodium, MW <10,000 | (C5H7NO3)n.xNa | 208106-41-6 | Details |
Benzyl 2-acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-a-D-galactopyranoside | C21H31NO11 | 1373368-54-7 | Details |
1-(2-Bromoethoxy)-4-methoxybenzene | C9H11BrO2 | 22921-76-2 | Details |
C8-Ceramide | C26H51NO3 | 74713-59-0 | Details |
5-Ethylidene-2-norbornene, sum of endo and exo, stabilizer with BHT | C9H12 | 16219-75-3 | Details |
3-Hydroxy-5-(trifluoromethyl)benzaldehyde | C8H5F3O2 | 1243312-51-7 | Details |
4-[(3,5-Dimethyl-1H-pyrazol-1-yl)methyl]-N'-hydroxybenzene-1-carboximidamide | C13H16N4O | 1158102-09-0 | Details |
Efavirenz | C14H9ClF3NO2 | 154598-52-4 | Details |
5-Methyl-4,5,6,7-tetrahydro-1H-indazole-7-carboxylic acid hydrochloride | C9H13ClN2O2 | 1795362-25-2 | Details |
Olsalazine sodium impurity A | Details |
(1R)-1-(4-Bromothiophen-2-yl)-2,2,2-trifluoroethan-1-ol | C6H4BrF3OS | 1423015-71-7 | Details |
6-Bromo-2h-1,3-benzoxazine-2,4(3h)-dione | C8H4BrNO3 | 24088-82-2 | Details |
DLX3 antibody | Details |
3,4-Dichlorobenzyl chloride | C7H5Cl3 | 102-47-6 | Details |
Recombinant Human IL-3 | Details |
5-Chloro-2-methylphenylboronic acid pinacol ester | C13H18BClO2 | 1352426-91-5 | Details |
2-bromo-4-(bromomethyl)pyridine hydrobromide | C6H6Br3N | 32938-44-6 | Details |
2-(Methyl-2-pyridylamino)ethanol | C8H12N2O | 122321-04-4 | Details |
2-sec-Butylphenol | C10H14O | 89-72-5 | Details |
(S)-(?’)-Limonene | C10H16 | 5989-54-8 | Details |
N,N-Dipropylpiperazine-1-sulfonamide | C10H23N3O2S | 99868-87-8 | Details |
5-Sulfamoylthiophene-2-carboxamide | C5H6N2O3S2 | 850340-83-9 | Details |
5-Bromo-2-fluoro-3-(trifluoromethyl)benzaldehyde | C8H3BrF4O | 1291487-26-7 | Details |
Methyl 2-chloro-5-(chlorosulfonyl)-4-fluorobenzoate | C8H5Cl2FO4S | 1154155-49-3 | Details |
H-Asp-Asn-Gln-OH | C13H21N5O8 | 286465-87-0 | Details |
5-Chloro-2-hydroxypyridine | C5H4ClNO | 4214-79-3 | Details |
Temsavir | C24H23N7O4 | 701213-36-7 | Details |
2-Chloro-3-methoxyphenol | C7H7ClO2 | 72232-49-6 | Details |
Tegaserod maleate | C20H27N5O5 | 189188-57-6 | Details |
Naphthalene-2-sulphonyl chloride | C10H7ClO2S | 93-11-8 | Details |
Ethyl D-glucopyranoside | C8H16O6 | 34625-23-5 | Details |
ARFGAP1 Blocking Peptide | Details |
4,4-Diethoxybut-1-yne | C8H14O2 | 13397-78-9 | Details |
(3-Cyclopropoxyphenyl)boronic acid | C9H11BO3 | 808140-97-8 | Details |
SIVmac239 - 20 | C79H119N19O22S2 | Details |
Iron(II) tetrafluoroborate - 40-45% aqueous solution | B2F8Fe | 15283-51-9 | Details |
3-(But-2-en-1-yloxy)pyridine | C9H11NO | 1567522-13-7 | Details |
2-[(2-Aminoethyl)(ethyl)amino]ethan-1-ol | C6H16N2O | 5753-48-0 | Details |
Oleic acid-ul-13C18 | C18H34O2 | 287100-82-7 | Details |
N-Methoxy-N-methyloxane-3-carboxamide | C8H15NO3 | 1187468-61-6 | Details |
5,7-Dimethoxy-2,3-dihydro-1H-indole | C10H13NO2 | 82260-13-7 | Details |
(Cyclohexylmethyl)(methoxy)amine hydrochloride | C8H18ClNO | 1803584-35-1 | Details |
Sniper(brd)-1 | C53H66ClN9O8S2 | 2095244-54-3 | Details |
1-(Oxolan-2-yl)ethan-1-amine hydrochloride | C6H14ClNO | 1401425-31-7 | Details |
H-YQGVNCTEV-OH | Details |
N-(3-Aminopropyl)-2-methylpropanamide hydrochloride | C7H17ClN2O | 1423032-81-8 | Details |
2-(1,5,3-Dithiazepan-3-yl)acetic acid | C6H11NO2S2 | 1966944-38-6 | Details |
CCT5 Blocking Peptide | Details |
H-GTVNLTWSR-OH | Details |
DCP2 Blocking Peptide | Details |
2-ethynylpyrrolidine hydrochloride | C6H10ClN | 1314937-87-5 | Details |
4-iodo-1-methyl-1H-pyrazol-3-amine | C4H6IN3 | 150187-16-9 | Details |
Streptavidin protein (HRP) | Details |
5-{[(3-Chlorophenyl)methyl]amino}-2,3-dihydro-1H-1,3-benzodiazol-2-one | C14H12ClN3O | 884994-41-6 | Details |
Methyl 3-amino-2-cyclohexylpropanoate hydrochloride | 2044712-59-4 | Details |
Ethyl N-(4-aminophenyl)-N-methylcarbamate hydrochloride | C10H15ClN2O2 | 1197542-76-9 | Details |
(4S)-4-Hydroxy-3,4-dihydro-2H-1λ?-benzothiopyran-1,1-dione | C9H10O3S | 1211548-70-7 | Details |
Methyl (2E)-3-(2,3,4-trimethoxyphenyl)acrylate | C13H16O5 | 116406-21-4 | Details |
2,2-Difluoro-1-[3-(propan-2-yloxy)phenyl]ethan-1-ol | C11H14F2O2 | 1503138-13-3 | Details |
3-[4-(Propan-2-yl)-1,3-thiazol-2-yl]piperidine | C11H18N2S | 1017184-32-5 | Details |
2,4-Dimethoxy-N-methylaniline | C9H13NO2 | 76030-55-2 | Details |
2-{[2-(4-Phenylpiperazin-1-yl)quinazolin-4-yl]amino}ethan-1-ol | C20H23N5O | 796887-98-4 | Details |
Normal Human Serum (Pool) | Details |
3-(tert-butyl)-6-((((5-chloro-2-methoxyphenyl)amino)thioxomethyl)amino)-1-methylindeno[2,3-d]pyrazol-4-one | C23H23ClN4O2S | 1024523-19-0 | Details |
RPL7 Blocking Peptide | Details |
3-(Cyclopropylamino)propanoic acid hydrochloride | C6H12ClNO2 | 1170463-02-1 | Details |
2-(Propan-2-yl)pyridine-4-carbaldehyde | C9H11NO | 172294-75-6 | Details |
3-Amino-2,4,6-trimethylphenol | C9H13NO | 114960-27-9 | Details |
8-Amino-2,3,4,5-tetrahydro-1H-2-benzazepin-3-one | C10H12N2O | 897014-18-5 | Details |
3-{[(1,3-Dimethyl-1H-pyrazol-4-yl)methyl]carbamoyl}propanoic acid | C10H15N3O3 | 522622-05-5 | Details |
5-(Difluoromethyl)-4-methylpyridin-2-amine | C7H8F2N2 | 1805301-60-3 | Details |
CTSD protein | Details |
5-(Aminomethyl)-5-phenylimidazolidine-2,4-dione hydrochloride | 201798-00-7 | Details |
TMEM30B Blocking Peptide | Details |
CNN3 Blocking Peptide | Details |
H-FTLSVDR^-OH | Details |
4-(2-Fluoroethyl)benzoic acid | C9H9FO2 | 819883-84-6 | Details |
H-LDELLQSQIEK^-OH | Details |
SGCB protein | Details |
2-(dimethylamino)-2-phenyl-acetonitrile | C10H12N2 | 827-36-1 | Details |
H-CVGGVV-OH | Details |
1-(Morpholin-4-yl)-2-(piperazin-1-yl)propan-1-one | C11H21N3O2 | 926241-15-8 | Details |
4-[(4-Fluorophenyl)methyl]piperidin-4-ol hydrochloride | C12H17ClFNO | 1429505-77-0 | Details |
(2E)-3-(Quinolin-6-yl)prop-2-enoic acid | C12H9NO2 | 754190-68-6 | Details |
4-Amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyridine-2-carboxylic acid hydrochloride | 2137791-52-5 | Details |
2-Hydroxy-3-phenylpropanamide | C9H11NO2 | 705-59-9 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |